NAs Clinical Trials
3 recruitingDrug
Phase 22Not Applicable1
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
Anti-PD-1 AntibodyChronic Hepatitis BPeg-IFNα
The Second Affiliated Hospital of Chongqing Medical University120 enrolled1 locationNCT05771402
Recruiting
Phase 2
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
Anti-PD-1 AntibodyChronic Hepatitis B
The Second Affiliated Hospital of Chongqing Medical University120 enrolled1 locationNCT05769816
Recruiting
Not Applicable
Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients
Chronic Hepatitis B
Beijing 302 Hospital50 enrolled1 locationNCT06457477